BioNTech US Inc (NTGN)

NTGN Chart

Catalysts

News and Press Releases

We searched over 50 sources and couldn't find any news or press releases related to BioNTech US.

Here are some articles we think you might like.

• Aptinyx Announces Poster Presentation Highlighting Preclinical Data on NYX-783 in Models of PTSD at the 2022 American Psychiatric Association Annual Meeting

  Business Wire | May 17th

  APTX
• Helius Medical Technologies, Inc. Announces Participation of Dr. Deborah Backus and Shepherd Center in its Therapeutic Experience Program

  GlobeNewsWire | May 17th

  HSDT
• Diffusion Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference

  GlobeNewsWire | May 17th

  DFFN
• Cytokinetics Provides Regulatory Update Related to New Drug Application for Omecamtiv Mecarbil

  GlobeNewsWire | May 17th

  CYTK
• Oragenics Issues Letter to Shareholders

  Business Wire | May 17th

  OGEN
• Decibel Therapeutics to Present at the H.C. Wainwright Global Investment Conference

  GlobeNewsWire | May 17th

  DBTX
• Palatin Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

  PRNewsWire | May 17th

  PTN
• Accuray Appoints Sandeep Chalke as SVP, Chief Commercial Officer

  PRNewsWire | May 17th

  ARAY
• Enveric Biosciences to Participate in the H.C. Wainwright Global Investment Conference on May 23-26, 2022

  PRNewsWire | May 17th

  ENVB
• Nephros Receives FDA 510(k) Clearance for HDF Assist Module

  GlobeNewsWire | May 17th

  NEPH
• InteliSwab® COVID-19 Rapid Test Validated to Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 Subvariants

  GlobeNewsWire | May 17th

  OSUR
• The Joint Corp. to Participate in Upcoming Conferences

  GlobeNewsWire | May 17th

  JYNT
• AVROBIO Reports Positive Data From Phase 1/2 Clinical Trial of Investigational Gene Therapy for Cystinosis, Including New Interim Data on Neurocognitive Measures

  Business Wire | May 17th

  AVRO
• GRAIL and Intermountain Healthcare Expand Partnership to Offer Galleri® Multi-Cancer Early Detection Blood Test to Eligible Patients in Utah

  Business Wire | May 17th

  ILMN
• 4D pharma Presents Late Breaking Abstract from Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma at the American Thoracic Society (ATS) 2022 International Conference

  Business Wire | May 17th

  LBPS

Company Info